New hepatic stellate cell subset drives liver fibrosis

Single-cell sequencing to inform design of targeted liver fibrosis therapies

A team including University of Edinburgh and Gilead researchers has used single-cell sequencing to zero in on a pathogenic subpopulation of hepatic stellate cells that could be targeted to treat liver fibrosis.

Reported in a November Cell Reports article, the research

Read the full 409 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE